BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 36182386)

  • 1. Abrupt transition of the efficient vaccination strategy in a population with heterogeneous fatality rates.
    Jhun B; Choi H
    Chaos; 2022 Sep; 32(9):093140. PubMed ID: 36182386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of infection fatality ratio and social contact matrices on vaccine prioritization strategies.
    Schulenburg A; Cota W; Costa GS; Ferreira SC
    Chaos; 2022 Sep; 32(9):093102. PubMed ID: 36182373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the best time interval between doses in a two-dose vaccination regimen to reduce the number of deaths in an ongoing epidemic of SARS-CoV-2.
    Souto Ferreira L; Canton O; da Silva RLP; Poloni S; Sudbrack V; Borges ME; Franco C; Marquitti FMD; de Moraes JC; Veras MASM; Kraenkel RA; Coutinho RM
    PLoS Comput Biol; 2022 Mar; 18(3):e1009978. PubMed ID: 35333872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive and optimized COVID-19 vaccination strategies across geographical regions and age groups.
    Molla J; Ponce de León Chávez A; Hiraoka T; Ala-Nissila T; Kivelä M; Leskelä L
    PLoS Comput Biol; 2022 Apr; 18(4):e1009974. PubMed ID: 35389983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose.
    Berec L; Levínský R; Weiner J; Šmíd M; Neruda R; Vidnerová P; Suchopárová G
    Sci Rep; 2022 May; 12(1):7638. PubMed ID: 35538118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal vaccination strategies for COVID-19 in population migration between two regions scenario.
    Zuo C; Ling Y; Guo Y; Zhang M; Meng Z; Xiang G
    Hum Vaccin Immunother; 2023 Aug; 19(2):2223108. PubMed ID: 37350470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
    COVIDSurg Collaborative, GlobalSurg Collaborative
    Br J Surg; 2021 Sep; 108(9):1056-1063. PubMed ID: 33761533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretically quantifying the direct and indirect benefits of vaccination against SARS-CoV-2 in terms of avoided deaths.
    Scutt G; Cross M; Waxman D
    Sci Rep; 2022 May; 12(1):8833. PubMed ID: 35614094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing vaccination priorities for different ages and age-specific vaccination strategies of COVID-19 using an SEIR modelling approach.
    Yang C; Yang Y; Li Y
    PLoS One; 2021; 16(12):e0261236. PubMed ID: 34936650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the transition of COVID-19 burden towards the young population while vaccines are rolled out in China.
    Cai J; Yang J; Deng X; Peng C; Chen X; Wu Q; Liu H; Zhang J; Zheng W; Zou J; Zhao Z; Ajelli M; Yu H
    Emerg Microbes Infect; 2022 Dec; 11(1):1205-1214. PubMed ID: 35380100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantial impact of post-vaccination contacts on cumulative infections during viral epidemics.
    Rochman N; Wolf Y; V Koonin E
    F1000Res; 2021; 10():315. PubMed ID: 34504684
    [No Abstract]   [Full Text] [Related]  

  • 16. Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India.
    Du Z; Wang L; Pandey A; Lim WW; Chinazzi M; Piontti APY; Lau EHY; Wu P; Malani A; Cobey S; Cowling BJ
    Nat Med; 2022 May; 28(5):934-938. PubMed ID: 35210596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
    Voigt A; Omholt S; Almaas E
    PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants.
    Kim D; Keskinocak P; Pekgün P; Yildirim İ
    Sci Rep; 2022 May; 12(1):7493. PubMed ID: 35523832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
    Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.